Based on 3 analysts offering 12 month price targets for Coya Therapeutics Inc
Min Forecast
$14.00+166.16%
Avg Forecast
$16.67+216.86%
Max Forecast
$18.00+242.21%
Should I buy or sell COYA stock?
Based on 3 analysts offering ratings for Coya Therapeutics Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although COYA's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates COYA as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More
Be the first to know when Wall Street analysts revise their COYA stock forecasts and price targets.
Is Coya Therapeutics Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: COYA) stock is to Strong Buy COYA stock.
Out of 3 analysts, 2 (66.67%) are recommending COYA as a Strong Buy, 1 (33.33%) are recommending COYA as a Buy, 0 (0%) are recommending COYA as a Hold, 0 (0%) are recommending COYA as a Sell, and 0 (0%) are recommending COYA as a Strong Sell.
What is COYA's earnings growth forecast for 2025-2025?
(NASDAQ: COYA) Coya Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Coya Therapeutics's earnings in 2025 is -$14,880,787.
In 2025, COYA is forecast to generate -$22,662,372 in earnings, with the lowest earnings forecast at -$28,097,997 and the highest earnings forecast at -$17,226,748.
What is COYA's revenue growth forecast for 2025-2025?
(NASDAQ: COYA) Coya Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Coya Therapeutics's revenue in 2025 is $3,554,061.
In 2025, COYA is forecast to generate $52,683,744 in revenue, with the lowest revenue forecast at $35,122,496 and the highest revenue forecast at $70,244,992.
What is COYA's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: COYA) forecast ROA is -51.1%, which is lower than the forecast US Biotechnology industry average of 101.93%.
What is COYA's Price Target?
According to 3 Wall Street analysts that have issued a 1 year COYA price target, the average COYA price target is $16.67, with the highest COYA stock price forecast at $18.00 and the lowest COYA stock price forecast at $14.00.
On average, Wall Street analysts predict that Coya Therapeutics's share price could reach $16.67 by Mar 27, 2026. The average Coya Therapeutics stock price prediction forecasts a potential upside of 216.86% from the current COYA share price of $5.26.
What is COYA's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: COYA) Coya Therapeutics's current Earnings Per Share (EPS) is -$0.98. In 2025, COYA's EPS is forecast to hit -$1.36 (min: -$1.68, max: -$1.03).
What is COYA's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: COYA) forecast ROE is -57.26%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.